Angiodynamics (ANGO) Debt to Equity (2016 - 2025)
Angiodynamics (ANGO) has disclosed Debt to Equity for 15 consecutive years, with $0.03 as the latest value for Q1 2025.
- For the quarter ending Q1 2025, Debt to Equity fell 38.07% year-over-year to $0.03, compared with a TTM value of $0.03 through Feb 2025, down 38.07%, and an annual FY2024 reading of $0.02, down 86.53% over the prior year.
- Debt to Equity was $0.03 for Q1 2025 at Angiodynamics, up from $0.03 in the prior quarter.
- Across five years, Debt to Equity topped out at $0.17 in Q2 2023 and bottomed at $0.01 in Q3 2023.
- Average Debt to Equity over 5 years is $0.07, with a median of $0.06 recorded in 2021.
- The sharpest move saw Debt to Equity surged 180.71% in 2021, then crashed 92.2% in 2023.
- Year by year, Debt to Equity stood at $0.06 in 2021, then skyrocketed by 152.48% to $0.15 in 2022, then plummeted by 83.97% to $0.02 in 2023, then increased by 13.51% to $0.03 in 2024, then grew by 1.29% to $0.03 in 2025.
- Business Quant data shows Debt to Equity for ANGO at $0.03 in Q1 2025, $0.03 in Q4 2024, and $0.02 in Q3 2024.